USPTO Rules on Patent Term Adjustment Set to Change Following CAFC Decision

February 5, 2019

The USPTO may be forced to rethink its regulations on calculating PTA following the Court of Appeals for the Federal Circuit precedential decision in Supernus Pharmaceuticals v Iancu, write Sharon Roberg-Perez, Jake Holdreith and Jeff Hovden of Robins Kaplan LLP.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Sharon E. Roberg-Perez, Ph.D.

Partner

Co-Chair, Diversity Committee

Jake M. Holdreith

Partner

Member of the Executive Board

Related Publications

November 2020
Explaining the Almost Unexplainable
David Prange, Benjamen Linden, Vivek Biswas - Intellectual Property Magazine
October 2, 2020
Does an AB Rating Fill Out a Skinny Label?
Jeffrey Alan Hovden, Oren D. Langer
September 22, 2020
Herbal Patent Protection
Shui Li - 闻宁阁 American Intellectual Property
August 26, 2020
INSIGHT: Avoiding Trade Secret Claims After Seeing a Competitor’s Crown Jewels
Jake Holdreith, David Prange, Emily Tremblay - Bloomberg Law
Back to Top